SCHEMBL17969736

SCHEMBL17969736

CC(c1c(Cl)ccc(F)c1Cl)N1CCNC(N)=C1/C=C(\N)C(=O)Nc1ccc(C(=O)N2CCCC2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MET P08581 10/20 0.43
MAP4K2 Q12851 1/20 0.43
MAP3K1 Q13233 1/20 0.43
AAK1 Q2M2I8 1/20 0.43
Q6ZSR9 Q6ZSR9 1/20 0.43
MAP4K5 Q9Y4K4 1/20 0.43
MAPT P10636 4/20 0.37
ALDH1A1 P00352 3/20 0.37
HPGD P15428 2/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
EPHX2 P34913 2/20 0.34
PKLR P30613 1/20 0.33
CNR1 P21554 1/20 0.33
CNR2 P34972 1/20 0.33
CHRNA7 P36544 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20859431 0.91 KMT2A (0.39) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859325 0.81 MAPT (0.38) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859415 0.77 MET (0.41) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL16615320 0.76 MET (0.45) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL16615101 0.75 MET (0.46) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859323 0.75 MET (0.44) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL17918726 0.75 MET (0.54) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL20859294 0.70 CCNC (0.41) MAPTALDH1A1HPGDMEN1KMT2A
SCHEMBL20859358 0.70 POLB (0.39) METMAP4K2MAP3K1AAK1Q6ZSR9
SCHEMBL17918857 0.70 MET (0.50) METMAP4K2MAP3K1AAK1Q6ZSR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3050884-B1 NEW CHEMICAL COMPOUNDS (DERIVATIVES) AND THEIR APPLICATION FOR THE TREATMENT OF ONCOLOGICAL DISEASES LIMITED LIABILITY COMPANY NATIONAL PHARMACEUTICAL TECH (RU) 2019-04-03 EP disclosed
EP-3050884-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES Limited Liability Company "National Pharmaceutical (RU) 2016-08-03 EP disclosed